The Epidermal Growth Factor Receptor in Breast Cancer: EGF-Related Peptides and Their Type I Receptor Tyrosine Kinases

By Fox Stephen B.   Harris Adrian L.  

Journal of Mammary Gland Biology and Neoplasia, Vol. 2, Iss. 2, 1997-04 ,pp. : 131-141

Springer Publishing Company

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Colorectal Cancer: A Potential Therapeutic Role for Gastrin-Releasing Peptide Receptor Antagonists

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 160-161

Karger

Access to resources Recommend Favorite

Human Epidermal Growth Factor Receptor Dimerization Analysis in Breast Cancer Diagnosis: Potential for Improving Testing Accuracy and Treatment Selection

By Spears Melanie   Bartlett John M.S.  

Molecular Diagnosis & Therapy, Vol. 13, Iss. 6, 2009-12 ,pp. : 359-365

Adis International

Access to resources Recommend Favorite

Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor‐2‐positive breast cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 4, 2018-02 ,pp. : 844-853

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in the Treatment of Breast Cancer: Recent Advances and Future Directions

By  

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 111-116

Bentham Science Publishers

Access to resources Recommend Favorite